Stage IVB Prostate Cancer AJCC v8 Recruiting Phase 2 Trials for Relugolix (DB11853)

IndicationStatusPhase
DBCOND0109404 (Stage IVB Prostate Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06378866Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE TrialTreatment
NCT05053152Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate CancerTreatment